Exelixis, Inc. (EXEL)
NASDAQ: EXEL · IEX Real-Time Price · USD
21.90
-0.22 (-0.99%)
At close: May 3, 2024, 4:00 PM
22.21
+0.31 (1.42%)
After-hours: May 3, 2024, 4:53 PM EDT
Exelixis Revenue
Exelixis had revenue of $1.85B in the twelve months ending March 31, 2024, with 10.98% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $425.23M with 4.02% year-over-year growth. In the year 2023, Exelixis had annual revenue of $1.83B with 13.60% growth.
Revenue (ttm)
$1.85B
Revenue Growth
+10.98%
P/S Ratio
3.45
Revenue / Employee
$1,409,653
Employees
1,310
Market Cap
6.38B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.83B | 219.15M | 13.60% |
Dec 31, 2022 | 1.61B | 176.09M | 12.27% |
Dec 31, 2021 | 1.43B | 447.43M | 45.31% |
Dec 31, 2020 | 987.54M | 19.76M | 2.04% |
Dec 31, 2019 | 967.78M | 113.95M | 13.35% |
Dec 31, 2018 | 853.83M | 401.35M | 88.70% |
Dec 31, 2017 | 452.48M | 261.02M | 136.34% |
Dec 31, 2016 | 191.45M | 154.28M | 415.05% |
Dec 31, 2015 | 37.17M | 12.06M | 48.03% |
Dec 31, 2014 | 25.11M | -6.23M | -19.87% |
Dec 31, 2013 | 31.34M | -16.11M | -33.96% |
Dec 31, 2012 | 47.45M | -242.19M | -83.62% |
Dec 31, 2011 | 289.64M | 104.59M | 56.52% |
Dec 31, 2010 | 185.05M | 33.29M | 21.93% |
Dec 31, 2009 | 151.76M | 33.90M | 28.76% |
Dec 31, 2008 | 117.86M | 4.39M | 3.87% |
Dec 31, 2007 | 113.47M | 14.80M | 15.00% |
Dec 31, 2006 | 98.67M | 22.71M | 29.90% |
Dec 31, 2005 | 75.96M | 23.10M | 43.71% |
Dec 31, 2004 | 52.86M | 1.32M | 2.56% |
Dec 31, 2003 | 51.54M | 7.22M | 16.29% |
Dec 31, 2002 | 44.32M | 3.32M | 8.09% |
Dec 31, 2001 | 41.01M | 16.25M | 65.62% |
Dec 31, 2000 | 24.76M | 14.25M | 135.58% |
Dec 31, 1999 | 10.51M | 8.24M | 362.59% |
Dec 31, 1998 | 2.27M | - | - |
Dec 31, 1997 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elanco Animal Health | 4.42B |
DENTSPLY SIRONA | 3.94B |
The Ensign Group | 3.85B |
Acadia Healthcare Company | 2.99B |
HealthEquity | 999.59M |
Ionis Pharmaceuticals | 787.65M |
Intra-Cellular Therapies | 464.37M |
Apellis Pharmaceuticals | 396.59M |
EXEL News
- 4 days ago - Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update - Business Wire
- 18 days ago - Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024 - Business Wire
- 2 months ago - Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March - Business Wire
- 2 months ago - Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments - GuruFocus
- 3 months ago - Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update - Business Wire
- 3 months ago - Exelixis to Webcast Fireside Chats as Part of Investor Conferences in February - Business Wire
- 3 months ago - Exelixis Announces Detailed Results of Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer Presented at ASCO GU 2024 - Business Wire
- 3 months ago - Exelixis to Release Fourth Quarter and Fiscal Year 2023 Financial Results on Tuesday, February 6, 2024 - Business Wire